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A B S T R A C T
Endoscopic examination of all patients with dyspepsia is hard to perform, because of high annual prevalence of dys-
pepsia and limited resource availability, especially in developing countries. Aim was to establish age cut off for upper
endoscopy in dyspeptic patients without alarming features according on incidence of gastric cancer in western Her-
zegovina in Bosnia and Herzegovina. Group of 2697 (1536 males, 1161 females) patients over 15 with chronic dyspep-
sia without alarming features and symptoms of gastroesophageal reflux disease, had been referred for a diagnostic up-
per endoscopy during 4 years. Study was prospective. All 34 gastric cancers were diagnosed in male patients above 55
years, and in female ones above 60. In the same age groups two thirds of gastric ulcers were found out. If the age cut off
for dyspeptic patients had been 55 years for male and 60 for female gender, the workload could be decreased by 50%.
The choice of alternative approaches is possible, depending on the level of diagnostic uncertainty, the patient and his
physician are prepared to accept. Age cut off determines diagnostic approach in chronic dyspepsia, and greatly de-
creases the endoscopy workload.
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Introduction
Upper endoscopy is a diagnostic method of choice in
uninvestigated dyspepsia because it allows identifica-
tion of structural causes of dyspepsia (1), but examina-
tion of all patients is hard to perform. The reason is high
annual prevalence of dyspepsia of about 25%1.The pro-
vision of the open access service results in resource
difficulty2 and long waiting lists3. British authors4 state
that only appropriately selected dyspeptic patients,
with a reasonably high probability of a clinically rele-
vant diagnosis, should be referred to endoscopy. The is-
sue is even more important in developing countries with
limited access to diagnostic devices. For instance, the
endoscopy facilities in Bosnia and Herzegovina are dis-
tributed only in big regional hospitals and clinics. In
Bosnia and Herzegovina the urea breath test for Heli-
cobacter pylori infection is not available to primary care
doctors. There is no data about prevalence of Helico-
bacter pylori infection in Bosnia and Herzegovina, but
according to surveys in adjacent countries the preva-
lence in the region is high. In the central and in the
northern counties of Croatia Helicobacter pylori infec-
tion prevalence is 59%, and 71.3% in the south part5,
neighbouring to western Herzegovina.
Endoscopy is generally accepted in patients with
alarming features, defined as findings in the disease
history and examination that suggest serious underly-
ing disease, and in elderly patients as well1,6. Increasing
age is related to higher frequency of organic disease in
dyspeptic patients7. There is no generally accepted con-
sensus about the age cut off for upper endoscopy, be-
cause it mainly depends on regional age-specific inci-
dence of gastric cancer. The aim of this study was to
establish age cut off for upper endoscopy in dyspeptic
patients without alarming features in western Her-
zegovina in Bosnia and Herzegovina. Reason for estab-
lishing the age cut off in western Herzegovina are envi-
ronmental factors, different from developed countries,
including low consumption of fruit and vegetables, con-
sumption of salted smoked foods, cigarette smoking and
low social and economic status.
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Patients and Method
Group of 2697 (1536 males, 1161 females) patients
over 15 with chronic uncomplicated dyspepsia, without
alarming features, who had been referred for a diagnos-
tic upper endoscopy at the Endoscopy unit in Mostar
Hospital during 4 years (from July 1, 1999 to June 30,
2003) were included in the study. Inclusion criteria were
chronic pain and discomfort in the upper abdomen dur-
ing 12 weeks in the preceding 12 months. All patients
were sent to open access Endoscopy Unit directly from
general practice. Experienced endoscopists, having
more than 500 procedures done, carried out all investi-
gations. The population of the study area was approxi-
mately 200,000.
Exclusion criteria included alarming features, when
indications for upper endoscopy are obligatory, as well
as symptoms of gastro-oesophageal reflux disease. Ex-
clusion criteria were: gastrointestinal haemorrhage,
anaemia, weight loss, persistent vomiting, dysphagia,
odynophagia, previous gastric surgery, previous peptic
ulcer, palpable mass in abdomen, non-steroidal anti-in-
flammatory drugs use, heartburn and acid regurgita-
tion.
Dyspepsia was defined as a chronic pain or discom-
fort centred in the upper abdomen8. Discomfort was
characterised by or associated with upper abdominal
fullness, early satiety, bloating or nausea. Patients with
predominant heartburn and acid regurgitation were
considered as having gastro-oesophageal reflux disease
and were excluded from dyspepsia.
Endoscopic findings were reported as non-organic
dyspepsia, oesophagitis, gastric ulcer, duodenal ulcer
and gastric cancer. Patients with normal endoscopic
findings and endoscopic findings of uncertain clinical
relevance such as gastric and duodenal erosions consti-
tuted the non-organic dyspepsia group.
Oesophagitis was diagnosed in the presence of muco-
sal breaks as oesophageal erosions and ulcers.
Peptic ulcer was diagnosed as an at least 5 mm ulcer
with depth. Routine biopsies were performed, but gas-
tric ulcers were only diagnosed if cancer was excluded.
Gastric cancer was confirmed by pathohystological
examinations of gastric biopsy specimens.
Statistics
Intergroup differences were evaluated using the ²
test. A p value of <0.05 was considered statistically sig-
nificant. Statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS) soft-
ware for Windows.
Results
In all 1536 male patients who underwent endoscopy
non-organic dyspepsia was found in 64.4%, gastric ulcer
in 7.2%, duodenal ulcer in 18.1%, gastric cancer in 1.8%,
and oesophagitis in 8.5% of patients (Table 1). In all
1161 female patients non-organic dyspepsia was found
in 78.4%, gastric ulcer in 6.1%, duodenal ulcer in 9.4%,
gastric cancer in 0.5%, and oesophagitis in 5.6% of pa-
tients (Table 2).
Out of 2697 analyzed patients 34 gastric cancers
were diagnosed. In male gender all twenty-eight gastric
cancers were diagnosed in patients above 55 years, and
in female gender all six gastric cancers were diagnosed
in patients above 60 years.
The frequency of non-organic dyspepsia findings was
significantly higher in female than in male patients
(²=32.94, df=11, p<0.05). The frequency of oesophagitis
(²=30.14, df=11, p<0.05), gastric ulcer (²=23.42, df=11,
p<0.05), duodenal ulcer (²=106.52, df=11, p<0.05), and
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TABLE 1












>70 159 (16.1) 22 (19.8) 33 (11.9) 10 (35.7) 12 (9.2) 236 (15.4)
66–70 145 (14.7) 18 (16.2) 35 (12.6) 7 (25.0) 8 (6.2) 213 (13.9)
61–65 126 (12.7) 18 (16.2) 31 (11.2) 7 (25.0) 17 (13.1) 199 (13.0)
56–60 73 (7.4) 14 (12.6) 16 (5.6) 4 (14.3) 6 (4.6) 113 (7.4)
51–55 73 (7.4) 5 (4.5) 17 (6.1) 0 (0) 13 (10.0) 108 (7.0)
46–50 78 (7.9) 13 (11.7) 39 (14.0) 0 (0) 16 (12.3) 146 (9.5)
41–45 96 (9.7) 11 (9.9) 17 (6.1) 0 (0) 19 (14.6) 143 (9.3)
36–40 57 (5.8) 4 (3.6) 28 (10.1) 0 (0) 9 (6.9) 98 (6.4)
31–35 69 (7.0) 1 (0.9) 22 (7.9) 0 (0) 19 (14.6) 111 (7.2)
26–30 39 (3.9) 2 (1.8) 22 (7.9) 0 (0) 5 (3.8) 68 (4.4)
21–25 33 (3.3) 2 (1.8) 17 (6.1) 0 (0) 3 (2.3) 55 (3.6)
16–20 41 (4.1) 1 (0.9) 1 (0.4) 0 (0) 3 (2.3) 46 (3.0)
Total 989 (100) 111 (100) 278 (100) 28 (100) 130 (100) 1536 (100)
*number of patients and annual percentage of total cases diagnosed in all age groups (in brackets)
gastric cancer (²=15.04, df=3, p<0.05) were significan-
tly higher in male patients than female ones.
Discussion
Absolute diagnostic certainty in dyspeptic patients is
possible only if all patients would be endoscoped, with-
out selection. In region with greatly reduced endoscopic
facilities, selection of patients for endoscopy is neces-
sary. According to the results of this study the incidence
of endoscopic findings in western Herzegovina is depend
not only on patients’ age, but also on gender. If the lower
age limit for upper endoscopy in dyspeptic patients had
been 55 in male and 60 in female population, all gastric
cancers and majority of ventricular ulcers (64.8% in
male and 69% in female patients) could have been diag-
nosed in these patients (761 male and 565 female pa-
tients). So, an endoscopy workload could be decreased
for about 50% for both genders. The physician should
decide if the separation of only one pathologic group (all
gastric cancer diagnosed) in dyspeptic patients without
alarming features and greatly reduced endoscopy work-
load compensate the diagnostic uncertainty of selective
endoscopic access. The choice of alternative approaches
is possible, depending on the level of uncertainty the pa-
tient and his physician are prepared to accept. The de-
crease in the age limit for open endoscopy access mini-
mises the probability of neglecting serious gastro-duo-
denal diseases – like gastric and duodenal ulcer.
For instance, if the age cut off for upper endoscopy
had been 45 years for male and 50 for female patients,
81% gastric ulcers and 61.5% duodenal ulcers in male,
and 86% and 56% respectively in female patients would
have been diagnosed, beside all cancers, and workload
would have been reduced by about 35% for both genders.
European panel on appropriateness of gastrointesti-
nal endoscopy concluded that an early endoscopy should
be used in patients with high probability of clinically
relevant diseases, such as peptic ulcer or gastric can-
cer9, and recommended endoscopy in patients older
than 45 years. The age cut off in Europe is standardised
on 45 years, as the incidence of gastric cancer in Europe
is very rare below 4510. Other authors reported different
results. Stanghellini et al.11 stated that the age over 40
is a risk indicator. Talley1 suggested that in Western
countries the age cut off of 50 might be appropriate.
Christie et al.12 found that gastric cancer is rare below
55 years, and presents with alarming features in 96% of
cases. These authors stated that the age limit could be
safely raised to 55 years. In all quoted studies the age
cut off was the same for both genders. According to the
results of this study the age cut off in western Herze-
govina is not the same for male and female gender, and
could be raised to 55 years for male dyspeptic patients.
Age of 60 could be appropriate for female patients, as,
beside the later occurrence of gastric cancer, non-or-
ganic dyspepsia is more frequent in female gender. By
this approach the substantial reduction of workload
might be realised in region of western Herzegovina in
which the health and financial resources are limited.
The cut off might be lower for ulcer disease, still with
substantial reduction of inappropriate investigations.
However, it should be emphasized that it is not easy
to transfer the results of our study to other populations,
since the prevalence of gastric cancer and gastric ulcer
usually varies from region to region.
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> 70 190 (20.9) 23 (32.4) 29 (26.6) 3 (50.0) 9 (13.8) 254 (21.9)
66–70 119 (13.1) 11 (15.5) 6 (5.5) 1 (16.7) 7 (10.8) 144 (12.4)
61–65 132 (14.5) 15 (21.1) 6 (5.5) 2 (33.3) 12 (18.5) 167 (14.4)
56–60 84 (9.2) 6 (8.5) 11 (10.1) 0 (0) 3 (4.6) 104 (9.0)
51–55 70 (7.7) 6 (8.5) 9 (8.3) 0 (0) 6 (9.2) 91 (7.8)
46–50 57 (6.3) 6 (8.5) 11 (10.1) 0 (0) 6 (9.2) 80 (6.9)
41–45 51 (5.6) 2 (2.8) 7 (6.4) 0 (0) 9 (13.8) 69 (5.9)
36–40 67 (7.4) 0 (0) 16 (14.7) 0 (0) 7 (10.8) 90 (7.8)
31–35 40 (4.4) 0 (0) 4 (3.7) 0 (0) 5 (7.7) 49 (4.2)
26–30 37 (4.1) 0 (0) 1 (0.9) 0 (0) 1 (1.5) 39 (3.4)
21–25 26 (2.9) 0 (0) 4 (3.7) 0 (0) 0 (0) 30 (2.6)
16–20 37 (4.1) 2 (2.8) 5 (4.7) 0 (0) 0 (0) 44 (3.8)
Total 910 (100) 71 (100) 109 (100) 6 (100) 65 (100) 1161 (100)
*number of patients and annual percentage of total cases diagnosed in all age groups (in brackets)
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IZBOR DOBNE GRANICE ZA ENDOSKOPSKU PRETRAGU U DISPEPSIJI U ZEMLJAMA U
RAZVOJU PREMA INCIDENCIJI KARCINOMA @ELUDCA
S A @ E T A K
Zbog visoke prevalencije dispepsije i ograni~enih resursa, endoskopiranje svih bolesnika s kroni~nom dispepsijom
je te{ko izvodljivo, pogotovo u zemljama u razvoju. Cilj studije je bio odrediti dobnu granicu u bolesnika s dispepsijom,
bez alarmantnih simptoma prema incidenciji karcinoma `eludca u zapadnoj Hercegovini. Skupina od 2697 bolesnika
(1536 mu{karaca, 1161 `ena) starijih od 15 godina s kroni~nom dispepsijom bez alarmantnih simptoma i simptoma
gastroezofagealne refluksne bolesti je bila endoskopirana tijekom ~etiri godine. Studija je bila prospektivna. Sva 34
slu~aja karcinoma `eluca su bila dijagnosticirana u osoba mu{kog spola starijih od 55 godina i u `enskih osoba sta-
rijih od 60 godina. U istim dobnim skupinama dijagnosticirano je dvije tre}ine `elud~anih ulkusa. Ukoliko je dobna
granica 55 godina za mu{ki i 60 godina za `enski spol, optere}enje endoskopske jedinice bi se smanjilo za 50%. Mogu}
je izbor alternativnih pristupa, ovisno o razini dijagnosti~ke nesigurnosti, koju su bolesnik i lije~nik spremni prihva-
titi. Dobna granica odre|uje dijagnosti~ki pristup u kroni~noj dispepsiji i mo`e znatno smanjiti optere}enje endo-
skopske jedinice.
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